Intravaginal practices and risk of bacterial vaginosis and candidiasis infection among a cohort of women in the United States

Obstetrics and Gynecology

Volumn 121, Issue 4, 2013, Pages 773-780

  Brown, Joelle M ^a   Hess, Kristen L ^a   Brown, Stephen ^a   Murphy, Colleen ^a   Waldman, Ava Lena ^a   Hezareh, Marjan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LUBRICATING AGENT; NON PRESCRIPTION DRUG; PETROLATUM;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BACTERIAL COLONIZATION; COHORT ANALYSIS; DEMOGRAPHY; DISEASE ASSOCIATION; DNA PROBE; ETHNIC DIFFERENCE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; NEGRO; PERSONAL HYGIENE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SEXUAL BEHAVIOR; SYMPTOM; TAMPON; UNITED STATES; VAGINA CANDIDIASIS; VAGINITIS;

ADOLESCENT; ADULT; AGED; CANDIDIASIS, VULVOVAGINAL; COHORT STUDIES; FEMALE; HUMANS; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS; UNITED STATES; VAGINAL CREAMS, FOAMS, AND JELLIES; VAGINAL DOUCHING; VAGINOSIS, BACTERIAL; YOUNG ADULT;

EID: 84876237608     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0b013e31828786f8     Document Type: Article

References (21)

1. Hoffman IF, Taha TE, Padian NS, Kelly CW, Welch JD, Martinson FE, et al. Nonoxynol-9 100 mg gel: multi-site safety study from sub-Saharan Africa. AIDS 2004; 18: 2191-5.
2. Watts DH, Rabe L, Krohn MA, Aura J, Hillier SL. The effects of three nonoxynol-9 preparations on vaginal flora and epithelium. J Infect Dis 1999; 180: 426-37.
3. Begay O, Jean-Pierre N, Abraham CJ, Chudolij A, Seidor S, Rodriguez A, et al. Identification of personal lubricants that can cause rectal epithelial cell damage and enhance HIV type 1 replication in vitro. AIDS Res Hum Retroviruses 2011; 27: 1019-24.
4. Low N, Chersich MF, Schmidlin K, Egger M, Francis SC, van de Wijgert JH, et al. Intravaginal practices, bacterial vaginosis, and HIV infection in women: individual participant data metaanalysis. PLoS Med 2011; 8:e1000416.
5. Hilber AM, Chersich MF, van de Wijgert JH, Rees H, Temmerman M. Vaginal practices, microbicides and HIV: what do we need to know? Sex Transm Infect 2007; 83: 505-8.
6. van de Wijgert JH, Chirenje ZM, Iliff V, Mbizvo MT, Mason PR, Gwanzura L, et al. Effect of intravaginal practices on the vaginal and cervical mucosa of Zimbabwean women. J Acquir Immune Defic Syndr 2000; 24: 62-7.
7. Pavlova SI, Tao L. In vitro inhibition of commercial douche products against vaginal microflora. Infect Dis Obstet Gynecol 2000; 8: 99-104.
8. Martino JL, Vermund SH. Vaginal douching: evidence for risks or benefits to women's health. Epidemiol Rev 2002; 24: 109-24.
9. Scholes D, Stergachis A, Ichikawa LE, Heidrich FE, Holmes KK, Stamm WE. Vaginal douching as a risk factor for cervical Chlamydia trachomatis infection. Obstet Gynecol 1998; 91: 993-7.
10. Rompalo AM, Gaydos CA Shah N, Tennant M, Crotchfelt KA, Madico G, et al. Evaluation of use of a single intravaginal swab to detect multiple sexually transmitted infections in active-duty military women. Clin Infect Dis 2001; 33: 1455-61.
11. Strauss RA, Eucker B, Savitz DA, Thorp JM Jr. Diagnosis of bacterial vaginosis from self-obtained vaginal swabs. Infect Dis Obstet Gynecol 2005; 13: 31-5.
12. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991; 29: 297-301.
13. Ashley-Morrow R Nollkamper J, Robinson NJ, Bishop N, Smith J. Performance of focus ELISA tests for herpes simplex virus type 1 (HSV-1) and HSV-2 antibodies among women in ten diverse geographical locations. Clin Microbiol Infect 2004; 10: 530-6.
14. Brown HL, Fuller DA Davis TE, Schwebke JR Hillier SL. Evaluation of the Affirm Ambient Temperature Transport System for the detection and identification of Trichomonas vaginalis, Gardnerella vaginalis, and Candida species from vaginal fluid specimens. J Clin Microbiol 2001; 39: 3197-9.
15. Zou G. A modified poisson regression approach to prospective studies with binary data. AmJ Epidemiol 2004; 159: 702-6.
16. McNutt LA, Wu C, Xue X, Hafner JP. Estimating the relative risk in cohort studies and clinical trials of common outcomes. AmJ Epidemiol 2003; 157: 940-3.
17. Hassan WM, Lavreys L, Chohan V, Richardson BA, Mandaliya K, Ndinya-Achola JO, et al. Associations between intravaginal practices and bacterial vaginosis in Kenyan female sex workers without symptoms of vaginal infections. Sex Transm Dis 2007; 34: 384-8.
18. Grimley DM, Oh MK Desmond RA, Hook EW III, Vermund SH. An intervention to reduce vaginal douching among adolescent and young adult women: a randomized, controlled trial. Sex Transm Dis 2005; 32: 752-8.
19. Foxman B, Barlow R DArcy H, Gillespie B, Sobel JD. Candida vaginitis: self-reported incidence and associated costs. Sex Transm Dis 2000; 27: 230-5.
20. Centers for Disease Control and Prevention, Division of Sexually Transmitted Diseases. Self-study STD module - vaginitis. Atlanta (GA): Centers for Disease Control and Prevention; 2010.
21. Verstraelen H, Verhelst R Roelens K Temmerman M. Antiseptics and disinfectants for the treatment of bacterial vaginosis: a systematic review. BMC Infect Dis 2012; 12: 148.